Bond Screener
Gilead Sciences
LEI 549300WTZWR07K8MNV44, SWIFT GILSUS6SXXX
Organization name
Gilead Sciences Inc
Country name
USA
Country of registration
USA
Industry
Pharmaceutical Preparation and Biotechnology
Credit Ratings
in foreign currency
Public debt
24,250 mln USD
New to Cbonds? · Take a 90-second tour of the platform.
Discover what you can do with Cbonds
Everything you need for fixed income research and monitoring.
- 00:23 Coverage
- 00:40 Bond screener
- 00:54 Parameters
- 01:10 Watchlist, Mobile app
- 01:15 Excel Add-in
Trading Schedule Issuer map
Quotes
/
/
/
pcs.
pcs.
pcs.
- «
- 1
- ...
- {{ quotes.page - 2 }}
- {{ quotes.page - 1 }}
- {{ quotes.page }}
- {{ quotes.page + 1 }}
- {{ quotes.page + 2 }}
- ...
- {{ quotesLastPage }}
- »
Quotes provided by information providers are indicative in nature
Profile
|
Gilead Sciences, Inc. is a research-based biopharmaceutical company that discovers, develops, and commercializes therapeutics to advance the care of patients suffering from life-threatening diseases. The Company primary areas of focus include HIV, AIDS, liver disease, and serious cardiovascular and respiratory conditions.
|
General information
-
Organization nameGilead Sciences Inc
-
Organization statusOperating organization
-
AddressCorporation Trust Center, Wilmington, USA, 19801
-
Site
-
IR Site
News
-
Gilead Sciences Just Won Its Third FDA Approval in Less Than 4 Months. Is the Stock Still Underrating This Turnaround Play?05/09/2026
-
Gilead Sciences Has Snapped Out of Its Slump -- and 1 Catalyst Is Doing Most of the Heavy Lifting26/08/2026
-
Gilead Sciences Has Quietly Become One of the Most Underrated Turnaround Stories in Healthcare. Here's Why Wall Street Is Excited.18/08/2026
-
GILD Q2 Earnings Call Raises Outlook on HIV and PrEP Strength07/08/2026
-
Gilead Sciences to Release Second Quarter 2026 Financial Results on Tuesday, August 4, 202621/07/2026
IFRS/US GAAP reports
| 2026 | |
| 2025 | |
| 2024 | |
| 2023 | |
| 2022 | |
| 2021 | |
| 2020 | |
| 2019 | |
| 2018 | |
| 2017 | |
| 2016 | |
| 2015 | |
| 2014 | |
Show more
Hide
Authorization required
You need to request access
Stocks
General information
-
Organization nameGilead Sciences Inc
-
Organization statusOperating organization
-
AddressCorporation Trust Center, Wilmington, USA, 19801
-
Site
-
IR Site
Codes
-
LEI549300WTZWR07K8MNV44
-
SWIFTGILSUS6SXXX
-
SIC2836 BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
-
NACE*** ***
-
NAICS*** ***
-
CIK0000882095
-
EIN94-3047598
